Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance Kindle Edition

★★★★★ 4.2 88 reviews

$175.75
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by school.anne.education
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
$175.75
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives May 8
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by school.anne.education
Free 30-day returns Details

Product details

Management number 219232148 Release Date 2026/05/03 List Price $70.30 Model Number 219232148
Category

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance provides an in-depth exploration of the complex molecular mechanisms that drive breast cancer progression. The book focuses on critical signaling pathways, including PI3K/Akt/mTOR, MAPK/ERK, JAK/STAT, Wnt/β-catenin, and Notch, elucidating their roles in tumor development, survival, and therapeutic resistance. The content offers a comprehensive overview of these pathways, detailing their dysregulation in breast cancer and implications for targeted therapeutic strategies. It discusses FDA-approved treatments, emerging therapies, and the mechanisms behind drug resistance, integrating recent research findings to highlight novel molecular targets and biomarker discovery. This book serves as a valuable resource for researchers, clinicians, and students, bridging the gap between basic molecular biology and clinical applications. By providing structured insights into complex signaling networks and therapeutic interventions, it equips readers with essential knowledge for developing innovative approaches to breast cancer management and improving patient outcomes.- Provides a detailed exploration of critical signaling pathways such as PI3K/Akt, MAPK, JAK/STAT, and Notch, elucidating their roles in tumor initiation, progression, and resistance to therapy- Discusses FDA-approved targeted therapies and emerging treatment strategies, including immunotherapy and personalized medicine- Addresses mechanisms of drug resistance and potential strategies for overcoming resistance- Includes case studies and biomarker-based approaches that link molecular mechanisms to clinical outcomes- Offers insights into ongoing clinical trials and future directions in breast cancer therapy Read more


Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.2 out of 5
★★★★★
88 ratings | 36 reviews
How item rating is calculated
View all reviews
5 stars
78% (69)
4 stars
6% (5)
3 stars
3% (3)
2 stars
2% (2)
1 star
11% (10)
Sort by

There are currently no written reviews for this product.